10314-91-7 Usage
Uses
Used in Pharmaceutical Research:
(13α,17aα)-14β,15β:21,23-Diepoxy-7α-hydroxy-4,4,8-trimethyl-17-oxa-D-homo-24-nor-5α-chola-20,22-diene-3,16-dione is used as a research compound for exploring its potential biological effects and pharmacological properties. Its unique structure may have implications in the development of new drugs and therapies.
Used in Biochemical Studies:
(13α,17aα)-14β,15β:21,23-Diepoxy-7α-hydroxy-4,4,8-trimethyl-17-oxa-D-homo-24-nor-5α-chola-20,22-diene-3,16-dione is used in biochemical studies to investigate its interactions with various biological systems and to understand its mechanisms of action. Further research is needed to fully elucidate its potential applications in medicine and biochemistry.
Used in Medical Applications:
While further studies are required, (13α,17aα)-14β,15β:21,23-Diepoxy-7α-hydroxy-4,4,8-trimethyl-17-oxa-D-homo-24-nor-5α-chola-20,22-diene-3,16-dione may have potential medical applications due to its distinct biological activity and pharmacological properties. Its potential uses in medicine could include the treatment of various diseases and conditions once its mechanisms of action are fully understood.
Check Digit Verification of cas no
The CAS Registry Mumber 10314-91-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,0,3,1 and 4 respectively; the second part has 2 digits, 9 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 10314-91:
(7*1)+(6*0)+(5*3)+(4*1)+(3*4)+(2*9)+(1*1)=57
57 % 10 = 7
So 10314-91-7 is a valid CAS Registry Number.
InChI:InChI=1/C26H34O6/c1-22(2)16-12-18(28)25(5)15(23(16,3)9-7-17(22)27)6-10-24(4)19(14-8-11-30-13-14)31-21(29)20-26(24,25)32-20/h8,11,13,15-16,18-20,28H,6-7,9-10,12H2,1-5H3
10314-91-7Relevant academic research and scientific papers
The Synthesis of a 1α,2α,3α-Triacetoxy Limonoid
Kehrli, Anne R. H.,Taylor, David A. H.,Niven, Margaret
, p. 2057 - 2065 (2007/10/02)
The report that Meerwein-Ponndorf reduction of gedunin (1a) gives 3α-hydroxy-3-deoxogedunin (2a) is wrong; the product is the 3β-epimer (2b). 3α-Acetoxy-7-deacetoxy-3-deoxo-7-oxgedunin (3c) was prepared by a stereospecific synthesis from cedrolide (1b), 7-deacetoxy-7-oxogedunin; osmium tetroxide oxidation then gave the 1,2α-glycol, isolated as the acetate (4a).Similarly, oxidation of the 3β-alcohol (3b) also gave the α-oriented glycol, as anticipated from the steric hindrance of the β-face of the molecule.Oxidation of the allylic alcohols (2b) or (3b), or of the allylic acetate (2d) with perbenzoic acid also takes place from the α-face of the molecule, giving the corresponding α-oxides (5a-c).The oxidation is pH sensitive; with a benzoate buffer the 7-oxo group in alcohol (3b) undergoes Baeyer-Villiger oxidation, giving the ε-lactone isolated as the acetate (6a).Opening of the oxide ring in the 3β,7α-diacetoxy oxide (5c) is complex.Identification of the products shows that the reaction involves participation by both the acetate groups.In contrast the 3β-acetoxy-7-oxo compound (5d) and the ε-lactone (6a) give the products of ring opening with assistance from the neighbouring acetate group, while the 3β-hydroxy compound (5b) gives the simple bromohydrin.
